DNMT3A R882H is a loss of function mutation; therefore, to kill DNMT3A R882H AML cells, it might be better to target its downstream-regulated key genes rather than DNMT3A R882H itself. This evidence concerns the gene DNMT3A and acute myeloid leukemia.